欢迎来到镇江鸿诚密封!鸿诚密封密封件厂家是有10年橡胶密封件定制、密封圈生产经验的厂家。

橡胶密封件厂家_机械密封件定制_O型橡胶密封圈_硅胶密封圈供应商

主营橡胶密封件、密封圈生产、密封件定制

---拥有10年专业加工定制经验的实力厂家---

24小时咨询热线

13913413721

打开客服菜单
新闻动态
您的位置 : 橡胶密封件 > 新闻动态 > 密封件慎用的添加剂种类及参考资料

密封件慎用的添加剂种类及参考资料

时间 : 2019-03-16 20:00:01 浏览量 : 27

8. 附件


密封件慎用的添加剂种类

商品名称

化学名称或可能含有的物质

CAS #

可能产生的风险物质

补白

硫化剂及硫化促进剂

Diak 1#

六亚甲基二胺氨基甲酸盐

143-06-6

有毒


促进剂M

(2-MBT)

2-巯基苯并噻唑

149-30-4

亚硝胺


促进剂DM

2,2'-二硫代二苯并噻唑

120-78-5

分解成2-巯基苯并噻唑


硫化剂HVA-2

N,N-间苯撑双马来酰亚胺

3006-93-7

有致癌性


促进剂BZ

二正丁基二硫代氨基甲酸锌

136-23-2

亚硝胺类化合物


促进剂EZ

二乙基二硫代氨基甲酸锌

136-94-7

亚硝胺类化合物


促进剂PZ

二甲基二硫代氨基甲酸锌

137-30-4

亚硝胺类化合物


促进剂DTDM

4,4,-二硫代二吗啉

103-34-4

有毒


促进剂TT

二硫代四甲基秋兰姆

137-26-8

易喷出、挥发性亚硝胺


其他

炉法炭黑

C

1333-86-4

含多环芳烃类物质



9. 参考资料


1)化学药品注射剂与塑料包装材料相容性研究技术辅导准则(试行)(国食药监注〔2012〕267号)

2)化学药品注射剂与药用玻璃包装容器相容性研究技术辅导准则(试行)(国家食品药品监督管理总局布告2015年第40号)

3)《中国人民共和国药典》2015年版 公例9621、9622

4)YBB00142002-2015药品包装材料与药物相容性实验辅导准则

5)ICH M7 (R1) Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk.

6)ICH Q3D Guideline for Elemental Impurities.

7)EMEA Guideline on Plastic Immediate Packaging Materials. (2005)

8)European Pharmacopoeia (Ph.Eur) Chapter 3 “Materials and Containers”.

9)United States Pharmacopeia (USP) Chapter 87, 88, 381, 1381, 1663, 1664.

10)Safety Thresholds and Best Practices for Extractables and Leachables in Orally Inhaled and Nasal Drug Products, PQRI Leachables and Extractables Working Group. (2006)

11)Comprehensive Determination of Extractables from Five Different Brands of Stoppers Used for Injectable Products. PDA Journal of Pharmaceutical Science and Technology 2009, 63 527-536.

12)Experimental Protocol for Qualitative Controlled Extraction Studies on Material Test Articles Representative of Prefilled Syringe (PFS) and Small Volume Parenteral (SVP) Container Closure Systems. PQRI Parenteral and Ophthalmic Drug Products Leachables and Extractables Working Group.(2011)

13)Perspectives on the PQRI Extractables and Leachables ''Safety Thresholds and Best Practices'' Recommendations for Inhalation Drug Products. PDA Journal of Pharmaceutical Science and Technology 2013, 67 413-429.

14)The Product Quality Research Institute (PQRI) Leachables and Extractables Working Group Initiatives for Parenteral and Ophthalmic Drug Product (PODP) . PDA Journal of Pharmaceutical Science and Technology 2013, 67 430-447.

15)Extractables Characterization for Five Materials of Construction Representative of Packaging Systems Used for Parenteral and Ophthalmic Drug Products. PDA Journal of Pharmaceutical Science and Technology 2013, 67 448-511.

16)Simulated Leaching (Migration) Study for a Model Container-closure System Applicable to Parenteral and Ophthalmic Drug Products (PODPs). PDA Journal of Pharmaceutical Science and Technology 2016, 70 1-46.

17)Jenke, D. Compatibility of Pharmaceutical Products and Contact Materials. Safety Considerations Associated with Extractables and Leachables. Hoboken, NJ. John Wiley & Sons. 2009.

18)Ball, Douglas J., Norwood, Daniel L., Stults, Cheryl L.M., Nagao, Lee M., ed.

Leachables and Extractables Handbook: Safety Evaluation, Qualification, and Best Practices Applied to Inhalation Drug Products. Hoboken, NJ. John Wiley & Sons. 2012.












标签:
相关新闻
cache
Processed in 0.003062 Second.